UK ENcorafenib and BInimetinib Real-world Study in Melanoma

Clinical trial NCT07022457 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07022457
Sponsor: Pierre Fabre Ltd
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Metastatic Melanoma, BRAF V600 Mutation Positive

Start date: 2025-07-31
Primary completion: 2028-01-13
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.